Sarepta Therapeutics, Inc. — Director's Dealing 2012

Aug 28, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2012-08-23

Reporting Person: Wigzell Hans Lennart Rudolf (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-08-23	Common Stock	A	833	—	Acquired	1666	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-08-23	Stock Option (Right to Buy)	$10.08	A	5000	Acquired	2022-08-23	Common Stock (5000)	Direct

Footnotes

F1: Grant of restricted stock, which shall vest in full on the earlier of (i) the anniversary date of the grant and (ii) the date of the 2013 annual meeting of shareholders.

F2: The number of shares reported reflects the 1-for-6 reverse stock split of the common stock of the Issuer effective as of July 11, 2012.

F3: Option shall vest in full on the earlier of (i) the anniversary date of the grant and (ii) the date of the 2013 annual meeting of shareholders.